Seeking Alpha

BioPharma Investor's  Instablog

After working for Big Pharma now for 7 years, I have started writing about Biopharmaceutical stocks and investments. I have worked for the top companies in the industry and have learned about Clinical Trials and Drug Approvals from the FDA. I most recently worked for a contract biotech... More
My blog:
BioPharma Investor
  • Swine Flu Stocks Tumble 0 comments
    Sep 25, 2009 03:08 PM | about stocks: CVM, SVA, NVAX, RHHBY.PK, GILD, GSK, BAX
    This past week we have seen Biotech Indexes falling between a 5-10% loss in two days trading. Additionally, there has been a massive Swine Flu Stock sell-off. Stocks of note are Novavax (NVAX), Sinovac (SVA), Biocryst (BCRX), AVI Biopharma (AVII), and Dynavax Technolog (DVAX).

    From 092509 afternoon trading:
    NVAX: 090109 6.65 high, Today at 3.81--> 43% loss
    SVA: 090109 10.46 high, Today at 7.90--> 25% loss
    BCRX:091509 11.67 high, Today at 8.26--> 29% loss
    AVII: 090109 2.08 high, Today at 1.58--> 24% loss
    DVAX: 091009 2.55 high, Today at 1.80--> 29% loss

    Today's selloff is a sign that these stocks are solely trading on hype and volatility, this hype could come back but these are volatile stocks that will rise and fall sharply. Yesterday's crash appears to have come from Congress' Health Care 80B Dollar Bill vote. In news today, the Senate Votes Down New Pharma Cuts. We have the G20 convention in Pittsburgh this week. But there is a lot affecting the market the past couple of days. The Federal Reserve has people talking too. Today, the Fed moves to be sooner, faster, stronger: Warsh, meaning faster rate hikes in this case.

    The market recovers slightly only to be set back down quickly to previous gains. It a state of reflux that is unpredictable. I see the swine flu stocks coming back but I do not think they will return to previous highs any time soon. Maybe at the height of flu season but with an early flu season we could all have some immunity to it by the end of the season. It's not that bad but it is a very contagious flu strain affecting young people at alarming rates. I do see these stocks rising again but there is no way to tell.

    It's a tough economy these days. We are not out of the woods just yet. I see these stocks rising again but not sure they can maintain their earnings over time. The big players in the markets don't lose as much value and can ride this economic storm out. They remain, Baxter(BAX), Novartis(NVS), Gilead(GILD), Roche(RHHBY), and GSK(GSK).

    Cel-Sci hasn't dropped all that much and was a gain at 1.66 trading. 
    CVM:  1.66 +0.06 (3.74%)

    Disclosure: No positions
    Themes: AVII, BCRX, Business, DVAX, Federal Reserve System, Health care, Investing, NVAX, SVA, Swine influenza, United States Congress Stocks: CVM, SVA, NVAX, RHHBY.PK, GILD, GSK, BAX
Back To BioPharma Investor's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Full index of posts »
Latest Followers
Posts by Ticker
ACAD, BAX, BCRX, CVM, CYTK, GILD, GSK, HEB, HGSI, JAZZ, MYL, NVAX, NVS, RHHBY.PK, SLXP, SPPI, SQNM, SVA, TSPT, VVUS

Latest Comments


Most Commented
  1. Sinovac Biotech China's Premiere Vaccine Maker (2 Comments)
  2. Acadia Pharmaceuticals: High Risk-Low Reward (2 Comments)
  3. Big Money in Swine Flu Stocks (1 Comment)
  4. Vivus' Qnexa Drug approved by FDA and Seeking a Partner to Sell Its Anti-Obesity Medication (1 Comment)
Posts by Themes
alli, 10 Rules of Investing BioPharma, 483 Letter, ACAD, Acadia Pharmaceuticals, Amgen, Anti-obesity medication, Arena Pharmaceuticals, ARYx Therapeutics, AVII, BCRX, Benlysta, BioCentury Thomson Reuters Newsmakers in the Biotech Industry Conference, Biocryst, Biopharma Investing, Biotech, Biotech IPO, Biotechnology and Pharmaceuticals, Breast cancer, Business, Cel-Sci, Cerezyme, Clinical trial, Clinical Trial Failure, Cumberland Pharmaceuticals, Cystic Fibrosis, CYTK, Cytokinetics, Down syndrome, DVAX, FDA, FDA Fast Track, Federal Reserve System, Flu Season, Gaucher Disease, Generics, Genetic disorder, Genzyme, Gilead Sciences HIV Prevention, Glaxo Smith Kline, GlaxoSmithKline, Google, H1N1, H1N1 Stocks, Health care, Hemispherx, High Risk Heart Failure, HIV, HIV Vaccine, Human Genome Sciences,
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.